AI Signal & Stock Analysis · Weak ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for BNTX is Weak ↓; the stock is at $92.99 (+0.95% today); neutral (RSI 53); technical trend is down-trend; news sentiment is positive.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Weak ↓ |
|---|---|
| Price | $92.99 |
| Change today | +0.95% |
| RSI (14) | 53.00 |
| Relative volume | 0.46 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $23.4B |
| Forward P/E | 0.00 |
| 52-week high | -25.0% away |
| 52-week low | +16.9% above |
| Technical trend | Down-trend (since 2024-01-26) |
| News sentiment | Positive |
| Sector | Healthcare-Biotech |
| Next earnings | 8/4/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns BNTX (BioNTech SE ADR) a Weak signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
BNTX's RSI is neutral (RSI 53). A reading above 70 is typically considered overbought and below 30 oversold.
BNTX is trading about 25% below its 52-week high and 17% above its 52-week low as of Aug 14 2026, 1:04 PM.
BNTX's next earnings date is 8/4/2026 8:30:00 AM.
BNTX is classified under Healthcare-Biotech in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.